Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.

G Fätkenheuer; C Duvivier; A Rieger; J Durant; D Rey; W Schmidt; A Hill; Y van Delft; S Marks

doi:10.1093/jac/dkr533

Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.

G Fätkenheuer, C Duvivier, A Rieger, J Durant, D Rey, W Schmidt, A Hill, Y van Delft, S Marks

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article › peer-review

29 Citations (Web of Science)

Original language	English
Pages (from-to)	685-690
Journal	JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume	67
Issue number	3
DOIs	https://doi.org/10.1093/jac/dkr533
Publication status	Published - 2012

Keywords

HIV-INFECTED PATIENTS
MYOCARDIAL-INFARCTION
THERAPY
RISK
COMBINATION
EFFICACY
SAFETY
INHIBITORS
LAMIVUDINE
REGIMENS

Access to Document

10.1093/jac/dkr533

Cite this

Fätkenheuer, G., Duvivier, C., Rieger, A., Durant, J., Rey, D., Schmidt, W., Hill, A., van Delft, Y., & Marks, S. (2012). Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , 67(3), 685-690. https://doi.org/10.1093/jac/dkr533

Fätkenheuer, G ; Duvivier, C ; Rieger, A et al. / Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial. In: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 2012 ; Vol. 67, No. 3. pp. 685-690.

@article{2451d5b0435b4714876c44e33e094981,

title = "Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.",

keywords = "HIV-INFECTED PATIENTS, MYOCARDIAL-INFARCTION, THERAPY, RISK, COMBINATION, EFFICACY, SAFETY, INHIBITORS, LAMIVUDINE, REGIMENS",

author = "G F{\"a}tkenheuer and C Duvivier and A Rieger and J Durant and D Rey and W Schmidt and A Hill and {van Delft}, Y and S Marks",

year = "2012",

doi = "10.1093/jac/dkr533",

language = "English",

volume = "67",

pages = "685--690",

journal = "JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY ",

issn = "0305-7453",

number = "3",

}

Fätkenheuer, G, Duvivier, C, Rieger, A, Durant, J, Rey, D, Schmidt, W, Hill, A, van Delft, Y & Marks, S 2012, 'Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.', JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , vol. 67, no. 3, pp. 685-690. https://doi.org/10.1093/jac/dkr533

Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial. / Fätkenheuer, G; Duvivier, C; Rieger, A et al.
In: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY , Vol. 67, No. 3, 2012, p. 685-690.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial.

AU - Fätkenheuer, G

AU - Duvivier, C

AU - Rieger, A

AU - Durant, J

AU - Rey, D

AU - Schmidt, W

AU - Hill, A

AU - van Delft, Y

AU - Marks, S

PY - 2012

Y1 - 2012

KW - HIV-INFECTED PATIENTS

KW - MYOCARDIAL-INFARCTION

KW - THERAPY

KW - RISK

KW - COMBINATION

KW - EFFICACY

KW - SAFETY

KW - INHIBITORS

KW - LAMIVUDINE

KW - REGIMENS

U2 - 10.1093/jac/dkr533

DO - 10.1093/jac/dkr533

M3 - Original Article

C2 - 22210755

SN - 0305-7453

VL - 67

SP - 685

EP - 690

JO - JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

JF - JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

IS - 3

ER -

Fätkenheuer G, Duvivier C, Rieger A, Durant J, Rey D, Schmidt W et al. Lipid profiles for etravirine versus efavirenz in treatment-naive patients in the randomized, double-blind SENSE trial. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 2012;67(3):685-690. doi: 10.1093/jac/dkr533